humeral fracture
Conditions
Interventions
Group A:Bupivacaine liposomes were 133mg / 10ml 66mg bupivacaine and diluted to 20ml using normal saline
Group B: 100mg/10ml Ropivacaine combined with 1µg/kg dexmedetomidine and diluted to 20ml using normal saline
Sponsors
Affiliated Shunde Hospital of Jinan University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age 18 years, AA I to III, patient undergoing upper limb fracture surgery
Exclusion criteria
Exclusion criteria: Patients who refuse to participate or who are not suitable to participate in the trial; There were contraindications to anesthesia and surgery. Patients with a history of neuropathy; Cervical spondylosis (i.e. disc herniation, myelopathy); People with neurological conditions (such as myelopathy) or other neurological conditions; Chronic pain; Patients allergic to related drugs; Severe cardiovascular and respiratory allergy; People with mental illness or cognitive impairment; Long-term use of opioids or other analgesics; Pregnant patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Consumption of opioid analgesics within 72 hours of surgery (converted to oral morphine); | — |
Secondary
| Measure | Time frame |
|---|---|
| Recovery quality within the PACU;Pain scores at 6,12,24,48,72 (at rest and exercise);Block-related adverse events;Duration of the motor and sensory blocks;Number of analgesic pump presses; | — |
Countries
China
Contacts
Public Contactzhang zhongqi
Affiliated Shunde Hospital of Jinan University
Outcome results
None listed